Table 5.
Nanosized delivery systems for anti-inflammatory essential oils.
| Bioactive Principle | Nanovector | Type of Delivery System | Experimental Model | Reference | |
|---|---|---|---|---|---|
| Oregano and Cassia EO | Nanoparticles | Corn zein NP | In vitro | [136] | |
| Thymol and carvacrol | Nanoparticles | Corn zein NP | In vitro | [137] | |
|
|
||||
| Cinnamon and thyme EO | Cyclodextrins | Inclusion in CD | In vitro | [140] | |
| LippiasidoidesEO (50–70% Thymol) | Nanoparticles | Alginate/cashew gum NP | In vitro | [141] | |
| Cumin and basil EO | Nanocapsules | Polyamide NC | In vitro | [143] | |